NTRA Sep 2024 135.000 call
| Previous Close | 4.0000 |
| Open | N/A |
| Bid | 2.4000 |
| Ask | 5.5000 |
| Strike | 135.00 |
| Expire Date | 2024-09-20 |
| Day's Range | 4.0000 - 4.0000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 2 |
Business WireNatera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients
AUSTIN, Texas, June 17, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced the launch of Prospera Heart™ with Donor Quantity Score (DQS), further enhancing Prospera’s ability to detect rejection in heart transplant patients.
Business WireNatera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
AUSTIN, Texas, June 03, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024 at 7:40 a.m. PT (10:40 a.m. ET).
Insider MonkeyNatera (NTRA) Raised Initial 2024 Guidance in Q1
Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. US markets performed strongly in Q1, with the S&P Index up 10.56%. Investor confidence rose with the anticipated soft landing of the market. However, Class A shares […]
